Few industries are subject to such extensive and intensive government controls as the pharmaceutical industry. Rigorous tests of safety and efficacy are insisted upon before drugs are allowed on the market. How they are marketed and distributed, who may sell the medicine and even how they are priced are subject to strict central control in most states. If government policy can influence industrial performance one might expect to find clear evidence from an examination of government-industry relations (GIR) in this sector.
Weitere Kapitel dieses Buchs durch Wischen aufrufen
- Palgrave Macmillan UK
Neuer Inhalt/© Stellmach, Neuer Inhalt/© Maturus, Pluta Logo/© Pluta, Rombach Rechtsanwälte/© Rombach Rechtsanwälte